These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Murphy GS; Szokol JW; Marymont JH; Greenberg SB; Avram MJ; Vender JS; Nisman M Anesthesiology; 2008 Sep; 109(3):389-98. PubMed ID: 18719436 [TBL] [Abstract][Full Text] [Related]
4. Neuromuscular monitoring: old issues, new controversies. Kopman AF J Crit Care; 2009 Mar; 24(1):11-20. PubMed ID: 19272534 [TBL] [Abstract][Full Text] [Related]
5. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Murphy GS; Szokol JW; Marymont JH; Greenberg SB; Avram MJ; Vender JS Anesth Analg; 2008 Jul; 107(1):130-7. PubMed ID: 18635478 [TBL] [Abstract][Full Text] [Related]
6. [Residual neuromuscular blockade]. Beaussier M; Boughaba MA Ann Fr Anesth Reanim; 2005 Oct; 24(10):1266-74. PubMed ID: 16039822 [TBL] [Abstract][Full Text] [Related]
7. [Incidence and complications of post operative residual paralysis]. Baillard C Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S41-5. PubMed ID: 19887276 [TBL] [Abstract][Full Text] [Related]
8. Residual neuromuscular blockade in myotonic dystrophy: lessons unlearned and sugammadex. Stewart PA; Phillips S; de Boer HD Anaesth Intensive Care; 2011 Jul; 39(4):756-7; author reply 757. PubMed ID: 21823393 [No Abstract] [Full Text] [Related]
9. Neuromuscular monitoring and postoperative residual curarization. Viby-Mogensen J; Claudius C; Eriksson LI Br J Anaesth; 2007 Aug; 99(2):297; author reply 297-9. PubMed ID: 17616566 [No Abstract] [Full Text] [Related]
10. Monitoring and pharmacologic reversal of a nondepolarizing neuromuscular blockade should be routine. Miller RD; Ward TA Anesth Analg; 2010 Jul; 111(1):3-5. PubMed ID: 20576958 [No Abstract] [Full Text] [Related]
11. [Erroneous attitudes in the use of neuromuscular blocking agents]. Ortiz-Gómez JR Rev Esp Anestesiol Reanim; 2002 Feb; 49(2):65-8. PubMed ID: 12025249 [No Abstract] [Full Text] [Related]
12. [Monitoring of neuromuscular block and prevention of residual paralysis]. Fuchs-Buder T; Meistelman C Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S46-50. PubMed ID: 19887277 [TBL] [Abstract][Full Text] [Related]
14. Residual neuromuscular block: rediscovering the obvious. Brull SJ; Naguib M; Miller RD Anesth Analg; 2008 Jul; 107(1):11-4. PubMed ID: 18635461 [No Abstract] [Full Text] [Related]
15. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Naguib M; Kopman AF; Ensor JE Br J Anaesth; 2007 Mar; 98(3):302-16. PubMed ID: 17307778 [TBL] [Abstract][Full Text] [Related]
16. A survey of current management of neuromuscular block in the United States and Europe. Naguib M; Kopman AF; Lien CA; Hunter JM; Lopez A; Brull SJ Anesth Analg; 2010 Jul; 111(1):110-9. PubMed ID: 19910616 [TBL] [Abstract][Full Text] [Related]
17. [Impact of a quality assurance program on the use of neuromuscular monitoring and reversal of muscle relaxants]. Motamed C; Bourgain JL Ann Fr Anesth Reanim; 2009 Apr; 28(4):297-301. PubMed ID: 19304447 [TBL] [Abstract][Full Text] [Related]
18. Managing neuromuscular block: where are the guidelines? Kopman AF Anesth Analg; 2010 Jul; 111(1):9-10. PubMed ID: 20576960 [No Abstract] [Full Text] [Related]